Identification of CX3CR1 -: A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1

被引:247
|
作者
Combadiere, C
Salzwedel, K
Smith, ED
Tiffany, HL
Berger, EA
Murphy, PM
机构
[1] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA
[2] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA
[3] CHU X Bichat, INSERM U479, F-75877 Paris, France
关键词
D O I
10.1074/jbc.273.37.23799
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fractalkine is a multimodular human leukocyte chemoattractant protein and a member of the chemokine superfamily. Unlike other human chemokines, the chemokine domain of fractalkine has three amino acids between two conserved cysteines, referred to as the CX3C motif. Both plasma membrane-associated and shed forms of fractalkine have been identified. Here, we show that the recombinant 76-amino acid chemokine domain of fractalkine is a potent and highly specific chemotactic agonist at a human orphan receptor previously named V28 or alternatively CMKBRL1 (chemokine beta receptor-like 1), which was shown previously to be expressed in neutrophils, monocytes, T lymphocytes, and several solid organs, including brain. CMKBRL1/V28 also functioned with CD4 as a coreceptor for the envelope protein from a primary isolate of HIV-1 in a cell-cell fusion assay, and fusion was potently and specifically inhibited by fractalkine. Thus CMKBRL1/V28 is a specific receptor for fractalkine, and we propose to rename it CX(3)CR1 (CX3C chemokine receptor 1), according to an accepted nomenclature system.
引用
收藏
页码:23799 / 23804
页数:6
相关论文
共 50 条
  • [1] Expression of CX3C chemokine, fractalkine, and its receptor CX3CR1 in experimental autoimmune anterior uveitis
    Fang, IM
    Lin, CP
    Yang, CM
    Chen, MS
    Yang, CH
    MOLECULAR VISION, 2005, 11 (52): : 443 - 451
  • [2] Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1)
    Lucas, AD
    Bursill, C
    Guzik, TJ
    Sadowski, J
    Channon, KM
    Greaves, DR
    CIRCULATION, 2003, 108 (20) : 2498 - 2504
  • [3] Role of the CX3C chemokine receptor CX3CR1 in the pathogenesis of atherosclerosis after aortic transplantation
    Rowinska, Zuzanna
    Koeppel, Thomas A.
    Sanati, Maryam
    Schelzig, Hubert
    Jankowski, Joachim
    Weber, Christian
    Zernecke, Alma
    Liehn, Elisa A.
    PLOS ONE, 2017, 12 (02):
  • [4] High expression of CX3C chemokine receptor 1 (CX3CR1) in human carotid plaques is associated with vulnerability of the lesions
    Masztalewicz, Marta
    Nowacki, Przemystaw
    Szydlowski, Lukasz
    Zukowski, Maciej
    Gutowski, Piotr
    FOLIA NEUROPATHOLOGICA, 2017, 55 (02) : 174 - 181
  • [5] An overview of the role of chemokine CX3CL1 (Fractalkine) and CX3C chemokine receptor 1 in systemic sclerosis
    Pezeshkian, Fatemehsadat
    Shahriarirad, Reza
    Mahram, Hadiseh
    IMMUNITY INFLAMMATION AND DISEASE, 2024, 12 (10)
  • [6] Solution structure and dynamics of the CX3C chemokine domain of fractalkine and its interaction with an N-terminal fragment of CX3CR1
    Mizoue, LS
    Bazan, JF
    Johnson, EC
    Handel, TM
    BIOCHEMISTRY, 1999, 38 (05) : 1402 - 1414
  • [7] Fractalkine/CX3CR1 and atherosclerosis
    Liu, Hong
    Jiang, Deqian
    CLINICA CHIMICA ACTA, 2011, 412 (13-14) : 1180 - 1186
  • [8] Computational study of the conformational ensemble of CX3C chemokine receptor 1 (CX3CR1) and its interactions with antagonist and agonist ligands
    Goode-Romero, Guillermo
    Dominguez, Laura
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2022, 117
  • [9] EVALUATION OF THE ROLE OF FRACTALKINE CHEMOKINE CX3CL1 AND ITS RECEPTOR CX3CR1 IN INFLAMMATORY MYOPATHIES
    Colafrancesco, S.
    Priori, R.
    Astorri, E.
    Scrivo, R.
    D'Amati, G.
    Giordano, C.
    Valesini, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 568 - 568
  • [10] The Chemokine CX3CL1 (Fractalkine) and its Receptor CX3CR1: Occurrence and Potential Role in Osteoarthritis
    Piotr Wojdasiewicz
    Łukasz A. Poniatowski
    Andrzej Kotela
    Jarosław Deszczyński
    Ireneusz Kotela
    Dariusz Szukiewicz
    Archivum Immunologiae et Therapiae Experimentalis, 2014, 62 : 395 - 403